Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial tested the hypothesis that continuous positive airway pressure (CPAP) would improve the survival rate without heart transplantation of patients who have central sleep apnea and heart failure. METHODS: After medical therapy was optimized, 258 patients who had heart failure (mean age [+/-SD], 63+/-10 years; ejection fraction, 24.5+/-7.7 percent) and central sleep apnea (number of episodes of apnea and hypopnea per hour of sleep, 40+/-16) were randomly assigned to receive CPAP (128 patients) or no CPAP (130 patients) and were followed for a mean of two years. During follow-up, sleep studies were conducted and measurements of the ejection fraction, exercise capacity, quality of life, and neurohormones were obtained. RESULTS: Three months after undergoing randomization, the CPAP group, as compared with the control group, had greater reductions in the frequency of episodes of apnea and hypopnea (-21+/-16 vs. -2+/-18 per hour, P<0.001) and in norepinephrine levels (-1.03+/-1.84 vs. 0.02+/-0.99 nmol per liter, P=0.009), and greater increases in the mean nocturnal oxygen saturation (1.6+/-2.8 percent vs. 0.4+/-2.5 percent, P<0.001), ejection fraction (2.2+/-5.4 percent vs. 0.4+/-5.3 percent, P=0.02), and the distance walked in six minutes (20.0+/-55 vs. -0.8+/-64.8 m, P=0.016). There were no differences between the control group and the CPAP group in the number of hospitalizations, quality of life, or atrial natriuretic peptide levels. An early divergence in survival rates without heart transplantation favored the control group, but after 18 months the divergence favored the CPAP group, yet the overall event rates (death and heart transplantation) did not differ (32 vs. 32 events, respectively; P=0.54). CONCLUSIONS: Although CPAP attenuated central sleep apnea, improved nocturnal oxygenation, increased the ejection fraction, lowered norepinephrine levels, and increased the distance walked in six minutes, it did not affect survival. Our data do not support the use of CPAP to extend life in patients who have central sleep apnea and heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinically a high loop gain can express itself as periodic breathing, for example, at high altitude,357 or in congestive heart failure (CHF).358,359”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [359]
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 3,004
Schuenemeyer, J. H., McCullagh, P., & Nelder, J. A. (1992) · Technometrics · doi:10.2307/1269238 · Cited by 2,667
McCullagh, P., & Nelder, J. A. (1983) · Springer eBooks · doi:10.1007/978-1-4899-3244-0 · Cited by 1,980
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
EEG Arousals: Scoring Rules and Examples
(1992) · Sleep · doi:10.1093/sleep/15.2.173 · Cited by 1,637
Research works printed but not linked: 4
- Bradley TD, 2001, Can J Cardiol, 17, 677
- Staats BA, 1984, Am Rev Respir Dis, 130, 59
- Johnstone DE, 1994, Can J Cardiol, 10, 613
- 10.1172/jci21748 · doi:10.1172/jci21748 · Paper page
Cited by
Items 501–600 of 1,000
Current treatment approaches and trials in central sleep apnea
Khayat, R., & Abraham, W. T. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.126 · Cited by 13
Floras, J. S. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00143.2021 · Cited by 13
Self-citationPositionspapier „Schlafmedizin in der Kardiologie“, Update 2021
Fox, H., Arzt, M. E., Bergmann, M. W., Bitter, T., Linz, D., Oldenburg, O., Penzel, T., Rillig, A., Schöbel, C., Sinha, A. M., et al. (2021) · Der Kardiologe · doi:10.1007/s12181-021-00506-4 · Cited by 15
Brown, L. K., & Javaheri, S. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000108 · Cited by 14
Bordier, P., Maurice-Tison, S., & Ramana, N. K. (2012) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.1908 · Cited by 12
Obstructive sleep apnea and nocturnal attacks of paroxysmal atrial fibrillation
Lin, C.-H., Timofeeva, M., O’Brien, T., & Lyons, O. D. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9840 · Cited by 15
Central Apneas Are More Detrimental in Female Than in Male Patients With Heart Failure
Gentile, F., Borrelli, C., Sciarrone, P., Buoncristiani, F., Spießhoefer, J., Bramanti, F., Iudice, G., Vergaro, G., Emdin, M., Passino, C., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024103 · Cited by 13
“New York Heart Association III to IV, n (%) 106 (19) 19 (16) 87 (20) 0.”
Zhang, X., Yuan, Y., Du, Y., Jiang, X.-T., & Zeng, H. (2015) · Lung · doi:10.1007/s00408-015-9684-z · Cited by 12
“PAP not only ameliorates SDB, improves LV function, but also alleviates the symptoms of HF [7, 8].”
BackgroundZhao, Z., Liu, Z., Luo, Q., Xiong, C., Ni, X., Zhang, J., Zhang, S., & Yang, Y. (2006) · Circulation Journal · doi:10.1253/circj.70.572 · Cited by 12
Cardiac pacing in sleep apnoea: diagnostic and therapeutic implications
SIMANTIRAKIS, E. N., & Vardas, P. E. (2006) · EP Europace · doi:10.1093/europace/eul105 · Cited by 12
Novel Therapies for the Treatment of Central Sleep Apnea
Javaheri, S., Germany, R. E., & Greer, J. J. (2016) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2016.01.004 · Cited by 12
Cardiovascular and cerebrovascular physiology in sleep
Hanak, V., & Somers, V. K. (2010) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52006-7.00019-8 · Cited by 12
“Treatment with a continuous nasal positive pressure device is often not effective in patients with heart failure (Bradley et al., 2005) or stroke (Sandberg et al.”
BackgroundDoes Body Mass Index Really Matter in the Management of Heart Failure? A Review of the Literature
Sagar, U. N., Ahmed, M. M., Adams, S., & Whellan, D. J. (2008) · Cardiology in Review · doi:10.1097/crd.0b013e31815d29e9 · Cited by 14
Sleep-disordered breathing in heart failure and the effect of cardiac resynchronization therapy
SIMANTIRAKIS, E. N., Schiza, S. E., Siafakas, N., & Vardas, P. E. (2008) · EP Europace · doi:10.1093/europace/eun190 · Cited by 14
“Although these measures seem to be beneficial, they are not currently recommended in clinical practice because they have no proven effect on mortality and morbidity.(6) Recently, the role of cardiac resynchronization therapy (CRT) in the treatment of sleep apnoea has been investigated in CHF patients.”
BackgroundResultInfluentialA Paradigm Shift in the Treatment of Central Sleep Apnea in Heart Failure
Mehra, R., & Gottlieb, D. J. (2015) · CHEST Journal · doi:10.1378/chest.15-1536 · Cited by 12
Screening for sleep-disordered breathing is recommended in patients with chronic heart failure
Oldenburg, O., Lamp, B., Freudenberg, G., & Horstkotte, D. (2007) · European Respiratory Journal · doi:10.1183/09031936.00073407 · Cited by 13
Sleep apnoea screening in heart failure? Not until benefit is proven!
Franklin, K. A. (2007) · European Respiratory Journal · doi:10.1183/09031936.00030507 · Cited by 12
Butt, J. H., Jering, K., de Boer, R. A., Claggett, B. L., Desai, A. S., Hernandez, A. F., Inzucchi, S. E., Jhund, P. S., Køber, L., Kosiborod, M., et al. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2023.08.027 · Cited by 11
Beyond Guideline-Directed Medical Therapy
Ilonze, O. J., Forman, D. E., Lemond, L. M., MYERS, J. N., Hummel, S. L., Vest, A. R., DeFilippis, E. M., Habib, E., & Goodlin, S. J. (2024) · JACC Heart Failure · doi:10.1016/j.jchf.2024.08.018 · Cited by 14
Sinha, A. M., Bauer, A., Skobel, E. C., Markus, K. U., Ritscher, G., Noelker, G., Breithardt, O. A., Brachmann, J., & Stellbrink, C. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.02289.x · Cited by 11
“(3) had a history of acute cardiopulmonary decompensation.”
BackgroundAlter, P. J., Apelt, S., Figiel, J. H., Rominger, M. B., Rupp, H., & HEITMANN, J. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.123 · Cited by 11
“Although several surrogate markers of heart failure improved during therapy, influences on the outcome remain controversial [2,8,9].”
Central Sleep Apnea in Patients with Heart Failure—How to Screen, How to Treat
Costanzo, M. R. (2020) · Current Heart Failure Reports · doi:10.1007/s11897-020-00472-0 · Cited by 12
Device Therapy for Heart Failure with Preserved Ejection Fraction
Salah, H. M., Levin, A. P., & Fudim, M. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2022.06.005 · Cited by 11
Pharmacological treatment for central sleep apnoea in adults
da Rocha, A. P., Pinto, A. C. P. N., Pachito, D. V., Drager, L. F., Lorenzi‐Filho, G., & Atallah, Á. N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012922.pub2 · Cited by 11
Sun, P., Porter, K. M., Randerath, W. J., Jarjoura, D. G., & Khayat, R. (2023) · Sleep And Breathing · doi:10.1007/s11325-023-02807-2 · Cited by 11
“Subsequently, a large randomized controlled trial (RCT) found no beneficial effects of CPAP on the mortality or cardiac function in patients with HFrEF-CSA [10].”
BackgroundMathew, D., Kosuru, B. P., Agarwal, S., Shrestha, U., & Sherif, A. A. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14430 · Cited by 12
“The CANPAP trial, where patients with CSA and HFrEF were randomized into groups treated with CPAP or not, showed improvements in left ventricular ejection fraction and 6 min walk test but failed to show any difference in hospitalizations or mortality in patients randomized to the CPAP arm.(20) For patients with CSA, a…”
MethodHuang, B., Huang, Y., Zhai, M., Zhou, Q., Ji, S., Liu, H., Zhuang, X., Zhang, Y., & Zhang, J. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.031186 · Cited by 12
“36 39 However, in the large sample SAVE (CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea) study, CPAP could not prevent cardiovascular events in patients with coronary heart disease or cerebrovascular disease with moderate- to-severe OSA.”
Nelson, K. A., & Trupp, R. J. (2015) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2015.07.008 · Cited by 13
CSA Is Not Beneficial Long Term in Heart Failure Patients with Reduced Ejection Fraction
Oldenburg, O., & Coats, A. J. S. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.003 · Cited by 13
Heart failure and sleep disordered breathing
Yoshihisa, A., & Takeishi, Y. (2017) · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · doi:10.5387/fms.2017-13 · Cited by 14
Management of Sleep Apnea in Heart Failure
Vazir, A., & Sundaram, V. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2018.06.008 · Cited by 12
Positive Airway Pressure Treatment for Obstructive Sleep Apnea–Hypopnea Syndrome
Buchanan, P. R., & Grunstein, R. R. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00107-9 · Cited by 15
Tamisier, R., Bocquillon, V., Treptow, E. C., Destors, M., Salvat, M., Borrel, E., & Pépin, J. (2019) · Respiration · doi:10.1159/000490734 · Cited by 11
Evolving Cardiac Electrical Therapies for Advanced Heart Failure Patients
Sharif, Z. I., Galand, V., Hucker, W. J., & Singh, J. P. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009668 · Cited by 11
Sleep-disordered breathing in patients with decompensated heart failure
Valdivia-Arenas, M. A., Powers, M., & Khayat, R. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9103-0 · Cited by 11
“In a recent randomized, single blinded, multi-center trial, CPAP improved oxygenation and ejection fraction but failed to improve transplantation-free survival or to decrease the number of hospitalizations [37].”
BackgroundThe occurrence of Cheyne–Stokes respiration in congestive heart failure: the effect of age
Peer, A., Lorber, A., Suraiya, S., Malhotra, A., & Pillar, G. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00133 · Cited by 12
Murase, K., Ono, K., Yoneda, T., Iguchi, M., Yokomatsu, T., Mizoguchi, T., Izumi, T., Akao, M., Miki, S., Nohara, R., et al. (2016) · Open Heart · doi:10.1136/openhrt-2015-000366 · Cited by 11
“According to the previous study, central sleep apnoea was defined as the absence of tidal volume for 10 s or more without thoracoabdominal motion, and central hypopnoea was defined as a reduction of 50% or more in tidal volume from baseline for 10 s or more without airflow limitation, as detected by the measurement of…”
MethodSiyam, M. A., & Benhamou, D. (2006) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2006.06.022 · Cited by 12
Are We Ready to Define Central Hypopneas?
Iber, C. (2013) · SLEEP · doi:10.5665/sleep.2434 · Cited by 11
Abraham, W. T., Oldenburg, O., Lainščak, M., Khayat, R., Asin, J., Ponikowski, P., Germany, R., McKane, S., & Costanzo, M. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15074 · Cited by 9
Badr, M. S., Khayat, R., Allam, J. S., Hyer, S., Mustafa, R. A., Naughton, M. T., Patil, S. P., Pien, G. W., Randerath, W. J., & Won, C. H. J. (2025) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.11860 · Cited by 12
“Sixteen RCTs 26,39 – 53 and 13 observational studies 25,54 – 65 investigated the use of CPAP to improve 1 or more of the following outcomes: excessive sleepiness, disease severity, cardiac outcomes, hospitalization, mortality, fatigue, or sleep architecture.”
InfluentialOccupational Health and Sleep Issues in Underserved Populations
Kalliny, M., & McKenzie, J. G. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2016.09.010 · Cited by 12
Sleep and breathing disorders in heart failure
Javaheri, S., & Germany, R. E. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-91532-8.00009-4 · Cited by 17
Valvular Heart Disease in Pregnancy
Stout, K. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5892-2.00025-8 · Cited by 10
Terziyski, K. V., Draganova, A. I., Taralov, Z. Z., Ilchev, I. S., & Kostianev, S. S. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12662 · Cited by 11
Update in respiratory sleep disorders: Epilogue to a modern review series
Malhotra, A., Morrell, M. J., & Eastwood, P. R. (2017) · Respirology · doi:10.1111/resp.13211 · Cited by 10
Hetland, A., Lerum, T. V., Haugaa, K. H., & Edvardsen, T. (2017) · Heart and Vessels · doi:10.1007/s00380-017-0951-1 · Cited by 10
Granitza, P., Kraemer, J. F., Schoebel, C., Penzel, T., Kurths, J., & Wessel, N. (2018) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/1.5039601 · Cited by 10
Ginter, G., & Badr, M. S. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-91532-8.00011-2 · Cited by 10
Sleep apnoea in congestive heart failure: one step forwards
Patel, S. R., Sykes, A. V., & Malhotra, A. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00377-6 · Cited by 10
Dynamic CO2 inhalation: a novel treatment for CSR–CSA associated with CHF
Wan, Z. H., Wen, F. J., & Hu, K. (2012) · Sleep And Breathing · doi:10.1007/s11325-012-0719-x · Cited by 10
The Association of Sleep Disordered Breathing with Heart Failure and Other Cardiovascular Conditions
Stopford, E., Ravi, K., & Nayar, V. (2013) · Cardiology Research and Practice · doi:10.1155/2013/356280 · Cited by 12
“Therefore, the data remains equivocal in support of CPAP improving life expectancy in heart failure patients with CSA [71, 72].”
BackgroundPositive Airway Pressure Therapy for Hyperventilatory Central Sleep Apnea
Javaheri, S., & Brown, L. K. (2017) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2017.07.006 · Cited by 10
Kato, T., Kasai, T., Yatsu, S., Murata, A., Matsumoto, H., Suda, S., Hiki, M., Shiroshita, N., Kato, M., Kawana, F., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00921 · Cited by 10
“Positive airway pressure (PAP) delivered by face masks has been used in the wide spectrum of heart failure (HF) care (Bradley et al., 2005; Arzt et al., 2007; Wang et al., 2007; Gray et al., 2008; Kasai et al., 2008; Kato et al., 2014; Khayat et al., 2015; Momomura et al., 2015; Nakano et al.,…”
BackgroundInfluentialDoes Providing Positive Airway Pressure for Sleep Apnea Change Health Care Utilization?
Derose, S. F., Zhou, H. C., Huang, B. Z., Manthena, P., Hwang, D., & Shi, J. M. (2018) · Medical Care · doi:10.1097/mlr.0000000000000963 · Cited by 11
Novel phrenic nerve stimulator treats Cheyne-Stokes respiration: polysomnographic insights
Schwartz, A. R., Sgambati, F. P., James, K. J., Goblish, T. P., Germany, R. E., Jackson, S. E., Samtani, N., & Berger, R. D. (2020) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8328 · Cited by 10
“Continuous PAP (CPAP) therapy is often used in practice, although a single multicenter randomized study failed to meet its primary mortality endpoint despite improvements in sleep-disordered breathing indices.(9) In contrast, a recent RCT studying safety and efficacy of TPNS demonstrated substantial, durable improveme…”
MethodLong-Term Changes in Sleep Disordered Breathing in Renal Transplant Patients: Relevance of the BMI
Mallamaci, F., Tripepi, R., D’Arrigo, G., Porto, G., Versace, M. C., Marino, C., Sanguedolce, M. C., Tripepi, G. L., & Zoccali, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061739 · Cited by 10
“The issue is important because SDB is a strong predictor of cardiovascular disease events in the general population [24] and entails a high death risk in patients with CKD not on dialysis [4], a category including renal transplant patients [25].”
Escourrou, P., & Roisman, G. L. (2010) · Médecine du Sommeil · doi:10.1016/j.msom.2010.09.002 · Cited by 13
Floras, J. S. (2005) · Current Heart Failure Reports · doi:10.1007/bf02696652 · Cited by 11
Self-citationYoshida, M., Ando, S., Kodama, K., Ebihara, K., Tanaka, K., Hayashi, A., Taguchi, E., Kadokami, T., Nakao, K., & Sakamoto, T. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.075 · Cited by 10
Management of Sleep Disordered Breathing in Patients with Heart Failure
Oates, C. P., Ananthram, M. G., & Gottlieb, S. S. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0387-7 · Cited by 10
Tafelmeier, M., Knapp, M., Lebek, S., Floerchinger, B., Camboni, D., Wittmann, S., Creutzenberg, M., Zeman, F., Schmid, Ç., Maier, L. S., et al. (2019) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-019-0196-6 · Cited by 10
Management of ACCF/AHA Stage C Heart Failure
Adigopula, S., Vivo, R. P., DePasquale, E. C., Nsair, A., & Deng, M. C.-H. K. (2013) · Cardiology Clinics · doi:10.1016/j.ccl.2013.09.012 · Cited by 10
Central sleep apnoea in HF—what can we learn from SERVE-HF?
Oldenburg, O., & Horstkotte, D. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.168 · Cited by 11
Huang, B., Huang, Y., Zhai, M., Zhou, Q., Ji, S., Liu, H., Zhuang, X., Zhang, Y., & Zhang, J. (2022) · Clinical Cardiology · doi:10.1002/clc.23925 · Cited by 10
Pathophysiology of Heart Failure
Cowie, M., & Poole-Wilson, P. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6705-2_18 · Cited by 12
Lungenerkrankungen und Herzfunktion
Rasche, K., Orth, M., Kutscha, A., & Duchna, H. W. (2006) · Der Internist · doi:10.1007/s00108-006-1763-z · Cited by 11
Baruah, R., Manisty, C., Giannoni, A., Willson, K., Mebrate, Y., Baksi, A. J., Unsworth, B., Hadjiloizou, N., Sutton, R., Mayet, J., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.806588 · Cited by 9
Sleep-Disordered Breathing in Patients with Heart Failure
Randerath, W. J., & Javaheri, S. (2016) · Current Sleep Medicine Reports · doi:10.1007/s40675-016-0047-y · Cited by 10
“Interestingly, survival was superior in the control group during the first 18 months of therapy but was overtaken by CPAP during the last study period [70].”
BackgroundIliou, M., Corone, S., Gellen, B., Denolle, T., Roche, F., Charles‐Nelson, A., & Darné, C. (2018) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2018.03.005 · Cited by 9
Khader, W., Fernandez, F., Seixas, A. A., Knowlden, A. P., Ellis, J. G., Williams, N. J., Hale, L. E., Branas, C. C., Perlis, M. L., Jean‐Louis, G., et al. (2020) · Sleep Health · doi:10.1016/j.sleh.2020.07.003 · Cited by 9
Buiret, G., Bechara, M., Plouin‐Gaudon, I., Bavozet, F., Dancea, O., Pujo, K., & Chidiac, F. (2021) · The Laryngoscope · doi:10.1002/lary.29439 · Cited by 10
Non-invasive positive pressure ventilation for central sleep apnoea in adults
Pinto, A. C. P. N., da Rocha, A. P., Drager, L. F., Lorenzi‐Filho, G., & Pachito, D. V. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012889.pub2 · Cited by 10
Lee, P., Wu, Y., Cheng, H., Wang, C., Chuang, L., Lin, C.-H., Hang, L., Yu, C., Hung, C., Liu, C., et al. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.08.024 · Cited by 9
A retrospective analysis of 4000 patients with obstructive sleep apnea in Okinawa, Japan
Nakamura, H., KANEMURA, T., Takara, C., TSUKAYAMA, A., Tohyama, K., Matsumoto, T., & Iseki, K. (2009) · Sleep and Biological Rhythms · doi:10.1111/j.1479-8425.2009.00395.x · Cited by 9
Park, H. S., Joo, E. Y., & Hong, S. B. (2009) · Journal of Korean Sleep Research Society · doi:10.13078/jksrs09015 · Cited by 10
Manisty, C., Willson, K., Davies, J. E., Whinnett, Z. I., Baruah, R., Mebrate, Y., Kanagaratnam, P., Peters, N. S., Hughes, A. D., Mayet, J., et al. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00064.2008 · Cited by 9
[Cardiovascular risk among adults with obstructive sleep apnea syndrome].
Torre-Bouscoulet, L. I., Meza-Vargas, M. S., Castorena-Maldonado, A. R., & Pérez‐Padilla, R. (2008) · PubMed · Cited by 9
Canadian Cardiovascular Society Consensus Conference Recommendations on Heart Failure 2006
Tsuyuki, R. T., & Arnold, J. M. O. (2006) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/171516350613900306 · Cited by 9
Sleep-Disordered Breathing—Do We Have to Change Gears in Heart Failure?
Cowie, M. (2016) · Current Heart Failure Reports · doi:10.1007/s11897-016-0304-x · Cited by 9
Nieminen, M. S., Fonseca, C., Brito, D. A., & Wikström, G. (2017) · European Heart Journal Supplements · doi:10.1093/eurheartj/sux003 · Cited by 11
Central Sleep Apnea and Periodic Breathing
Wellman, A., & White, D. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00100-6 · Cited by 10
Sleep-disordered Breathing in Heart Failure – Current State of the Art
Cowie, M., Woehrle, H., Oldenburg, O., Damy, T., van der Meer, P., Erdmann, E., Metra, M., Zannad, F. M., Trochu, J., Gullestad, L. L., et al. (2015) · Cardiac failure review · doi:10.15420/cfr.2015.01.01.16 · Cited by 9
“The study was stopped prematurely after enrolment of 258 of the planned 408 when analysis did not show a beneficial effect of CPAP treatment on survival.(85) However, a post hoc evaluation suggested that morbidity and mortality might be improved if there was an early and significant reduction in AHI to <15/h during CP…”
MethodFisser, C., Gall, L., Bureck, J., Vaas, V., Priefert, J., Fredersdorf, S., Zeman, F., Linz, D., Woehrle, H., Tamisier, R., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.896917 · Cited by 9
“However, in the CANPAP trial suppression of CSA by means of CPAP had no effect on mortality compared to the control group (26).”
BackgroundSleep Apnea-Hypopnea Syndromes and Heart Failure
Arias, M. A., Rio, F. G., Alonso‐Fernández, A., & Sánchez, A. M. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(07)60174-1 · Cited by 12
Sleep-Disordered Breathing In Heart Failure
Pearse, S. G., Cowie, M., Sharma, R., & Vazir, A. (2015) · European Cardiology Review · doi:10.15420/ecr.2015.10.2.89 · Cited by 10
“Physiologically, OSA has been shown to acutely reduce stroke volume and cardiac output overnight and that this reduction is ameliorated by CPAP therapy.45 Measures of cardiac sympathetic tone are also reduced by CPAP in those with OSA.46 There are conflicting reports regarding the impact of cardiac resynchronisation t…”
MethodInfluentialChen, C., Wen, T., & Liao, W. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.06.72 · Cited by 9
“In addition, from the results of previous study (29), CPAP was the preferred first-line therapy for symptomatic patients with hyperventilation-related CSA.”
ResultCommon Sleep Problems in ICU: Heart Failure and Sleep-Disordered Breathing Syndromes
Naughton, M. T. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2008.02.004 · Cited by 9
Das obstruktive Schlafapnoesyndrom
Heinzer, R. C., & Aubert, J. (2007) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2007.06267 · Cited by 13
Bitter, T., Zwenke, A., Dimitriadis, Z., Fischbach, T., Möllenberg, M., Dohrmann, J., Prinz, C., Afsah, M., Horstkotte, D., & Oldenburg, O. (2013) · European Respiratory Journal · doi:10.1183/13993003/erj.42.suppl_57.p309 · Cited by 9
Spießhoefer, J., Giannoni, A., Borrelli, C., Sciarrone, P., Husstedt, I., Emdin, M., Passino, C., Kahles, F., Dawood, T., Regmi, B., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.934372 · Cited by 9
“This is of major clinical interest as two large multicentric studies using either continuous positive airway pressure or assisted servo-ventilation to treat CA in HFrEF showed neutral or even detrimental impact on survival (Bradley et al., 2005; Cowie et al., 2015; Eulenburg et al., 2016) In patients with HFrEF and Hu…”
BackgroundMethodNaito, R., Kasai, T., Tomita, Y., Kasagi, S., Narui, K., & Momomura, S. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1156353 · Cited by 8
“However, previous clinical trial examining the efficacy of CPAP therapy in patients with HF and CSA, revealed that CPAP therapy did not significantly reduce incident clinical outcomes including mortality, heart transplantation or hospitalization for cardiovascular events (6, 8, 12, 13).”
BackgroundYatsu, S., Woo, A., Horváth, C., Tobushi, T., Logan, A. G., Floras, J. S., TOMLINSON, G. A., Bradley, T. D., Lorenzi-Filho, G., Drager, L., et al. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2025.02.016 · Cited by 9
Self-citationBrown, L. K. (2008) · CHEST Journal · doi:10.1378/chest.07-3019 · Cited by 8
Treatment of sleep disordered breathing in congestive heart failure
Krachman, S. L., D’Alonzo, G. E., Permut, I., & Chatila, W. M. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9099-5 · Cited by 9
“These studies stimulated the performance of a larger multicenter Canadian Continuous Positive Airway Pressure Trial for Congestive Heart Failure (CANPAP) in order to specifically evaluate the effects of CPAP therapy on transplant-free survival in CHF patients with CSR [18].”
MethodResultPack, A. I. (2010) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52006-7.00027-7 · Cited by 8
Mansukhani, M. P., Kolla, B. P., Naessens, J. M., Gay, P. C., & Morgenthaler, T. I. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7584 · Cited by 9
“36,39 The recent SERVE-HF study, on the other hand, showed an increase in all-cause and cardiovascular mortality with ASV treatment in patients with CSA and HF with reduced EF at 12 months, contrary to expectation.”
Noninvasive Positive Pressure Ventilation for Acute Decompensated Heart Failure
Hieda, M. (2020) · Heart Failure Clinics · doi:10.1016/j.hfc.2020.02.005 · Cited by 8
Contemporary Issues in the Diagnosis and Treatment of Obstructive Sleep Apnea
Rubins, J. B., & Kunisaki, K. M. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.07.1790 · Cited by 10
Treatment of Sleep Apnea in Heart Failure
Backer, W. D., & Javaheri, S. (2007) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2007.08.002 · Cited by 8
Metadata
- Authors
- Bradley, T. D., Logan, A. G., Kimoff, R. J., Sériès, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., Smilovitch, M., Tomlinson, G., & Floras, J. S.
- Affiliations
- University of Toronto (CA)
- McGill University (CA)
- Université Laval (CA)
- Dalhousie University (CA)
- Western University (CA)
- University of Calgary (CA)
- University of Regensburg (DE)
- University of British Columbia (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-11-10
- Volume
- 353
- Issue
- 19
- Pages
- 2025-2033
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130637800
- Semantic Scholar
- 266ff6f4028ab04f061c1b59c2a17a2fc2990e32
- Cited by
- 1,189
- References
- 45
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 33 · 2023: 47 · 2022: 45 · 2021: 51 · 2020: 40 · 2019: 55 · 2018: 50 · 2017: 70 · 2016: 87 · 2015: 68 · 2014: 44 · 2013: 67 · 2012: 62
- FWCI
- 45.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- continuous positive airway pressure, central sleep apnea, heart failure, nocturnal oxygen saturation, norepinephrine, ejection fraction, exercise capacity, neurohormones, atrial natriuretic peptide, quality of life, heart transplantation, sleep-disordered breathing, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction
- MeSH terms
- Aged, Female, Follow-Up Studies, Heart Failure, Humans, Male, Middle Aged, Norepinephrine, Stroke Volume, Survival Rate, Proportional Hazards Models, Heart Transplantation, Treatment Outcome, Exercise Tolerance, Sleep Apnea, Central, Continuous Positive Airway Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.